Table 3. Co-dominant model of the nine validation sample.
| SNP | P-value (n=1781) | B–H criterion | OR |
|---|---|---|---|
| APEH | |||
| rs4855881 | 0.0199 | 0.011 | 0.78 |
| APEH | |||
| rs2960548 | 0.0317 | 0.022 | 0.79 |
| Postfox01a | |||
| rs1744659 | 0.1368 | 0.033 | 1.19 |
| IL-1β | |||
| rs1143634 | 0.2180 | 0.044 | 0.87 |
| SELP | |||
| rs6136 | 0.5000 | 0.056 | 1.10 |
| TNFrsf1a | |||
| rs4149570 | 0.7933 | 0.067 | 1.03 |
| LEPR | |||
| rs1137100 | 0.8343 | 0.078 | 1.02 |
| IL-10 | |||
| rs1800896 | 0.9005 | 0.089 | 1.01 |
| GHRL | |||
| rs42451 | 0.9426 | 0.100 | 1.01 |
Abbreviations: APEH=acylpeptide hydrolase; B–H= Benjamini–Hochberg; IL=interleukin; OR=odds ratio; SNP=single-nucleotide polymorphism; TNF=tumour necrosis factor.